Stay updated on Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.

Latest updates to the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page
- Check4 days agoChange DetectedA platform revision was applied, updating the site from version 3.6.2 to 3.6.3. This is a backend software update that does not change the study content.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a minor maintenance update to the study record page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe recruitment status on the page was updated to show that enrollment is closed (No longer looking for participants), clarifying that the study is not accepting new participants.SummaryDifference0.4%

- Check32 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new build of the page rather than a substantive change to the study details.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.4 was added, replacing Revision: v3.5.3. This indicates a small system/UI update and does not modify study details.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a maintenance or platform update rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib With Cetuximab in Head and Neck Cancer Clinical Trial page.